STEPHANIE SILL: Open Payments
NPI 1003496563 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,082 in 207 payments from 39 companies in 2025. Trend: 2023 $3,285 · 2024 $5,340 · 2025 $4,082
Food & beverage: $4,026Education: $57
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $480 |
| Teva Pharmaceuticals USA, Inc. | 43 | $345 |
| Biogen, Inc. | 13 | $254 |
| Eisai Inc. | 6 | $242 |
| UCB, Inc. | 11 | $218 |
| Janssen Biotech, Inc. | 5 | $182 |
| Alexion Pharmaceuticals, Inc. | 7 | $171 |
| Lilly USA, LLC | 9 | $158 |
| EMD Serono, Inc. | 8 | $153 |
| Lundbeck LLC | 7 | $142 |
Products named: LEQEMBI, AUSTEDO XR, REXULTI, VYALEV, ULTOMIRIS, Briviact, QULIPTA, PERCEPT PC BRAINSENSE.
Industry payments across VA — which companies pay providers there.
